TLDR Human bone cells mainly produce a type 1 enzyme that may help regulate bone health.
The study investigated the expression of 5alpha-reductase (5alpha-R) isozymes in human osteoblast-like cells (hOB cells) cultured from bone, using samples from six donors. It was found that these cells predominantly expressed the type 1 isozyme, as opposed to genital skin fibroblasts, which primarily expressed type 2. The study used selective inhibitors to determine the activity of these isozymes, finding that LY191704, a type 1 inhibitor, effectively blocked 5alpha-R activity in hOB cells, while finasteride, a type 2 inhibitor, was less effective. The research suggested that local production of dihydrotestosterone (DHT) in bone, catalyzed by 5alpha-R type 1, might play a role in bone homeostasis due to the presence of androgen receptors in bone cells.
29 citations
,
April 1995 in “Endocrinology” Finasteride doesn't affect bone density in male rats.
53 citations
,
June 1993 in “Proceedings of the National Academy of Sciences of the United States of America” LY191704 is a compound that effectively blocks a specific enzyme involved in hormone conversion and could help treat enlarged prostate and hair loss.
48 citations
,
November 1992 in “Clinical Endocrinology” Long-term finasteride use doesn't change bone density or metabolism.
June 2023 in “Clinica Chimica Acta” Finasteride and dutasteride effectively reduce DHT in hair, which may help evaluate their treatment success for hair loss.
215 citations
,
November 2006 in “Journal of The American Academy of Dermatology” Dutasteride more effective for hair growth, but has more side effects than finasteride.
65 citations
,
October 1999 in “Journal of The American Academy of Dermatology” Finasteride effectively reduces hair loss by decreasing androgen levels.
6 citations
,
August 1996 in “The Journal of Clinical Endocrinology and Metabolism” MK-386 and finasteride together effectively reduce DHT levels, potentially treating acne and male pattern baldness.
59 citations
,
September 1994 in “The Journal of Clinical Endocrinology and Metabolism” Finasteride reduces scalp DHT levels, potentially treating male pattern baldness.